Pancreatic cancer kills 95 percent of the people diagnosed with it.
Chemotherapy helps, but only extends survival for a few months.
In Healthy Living, Courtney Hunters shows us a new tool that allows researchers to accurately study how the cancer develops.
A U.S. patent is pending on the gene delivery technology developed by Bruno Doiron.
Obesity and diabetes are major risk factors for pancreatic cancer. Researchers say the new technology can be used to examine this link.